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Abstract	  
Currently, opportunistic fungal infections are considered a serious problem regarding 
public health. Despite the advances towards the synthesis of new antifungal agents, an 
increasing incidence of drug-resistant microorganisms has been observed. In this sense, 
other alternatives are necessary. In the present work, the antifungal activity of extracts 
from ten different plants, commonly used in folk medicine, were evaluated against 
nineteen Candida strains, including C. albicans, C. glabrata, C. parapsilosis and C. 
tropicalis species. Although the majority of the extracts had no antimicrobial effect, 
Juglans regia extract was very effective, exerting an inhibitory effect against all the 
tested Candida strains, while Eucalyptus globulus was effective against seventeen of 
them. Pterospartum tridentatum and Rubus ulmifolius presented similar antifungal 
effects, being effective against six Candida strains. The diameter of halo ranged, 
respectively, between 9-14 mm and 9-21 mm to the mentioned plant extracts, and the 
MIC50 values evidenced mainly a fungistatic activity. Both extracts showed similar 
MIC50 values for C. albicans strains, while C. parapsilosis and C. glabrata were more 
sensible to E. globulus. Otherwise, all the C. tropicalis strains were more sensible to J. 
regia. Overall, hydromethanolic plant extracts could constitute promissory alternatives 
to the traditional antifungal agents.  
 
Keywords: Medicinal plants; Hydromethanolic extracts; Antifungal activity; Candida 
species 
	   3	  
1. Introduction 
Medicinal plants have been widely used, since pre-historic era, not only to improve 
health and well-being but also to treat some specific diseases/disorders (Agarwal et al., 
2010; Bakkali et al., 2008; Sher, 2009). In the last years, those natural matrices have 
sparked an increasing interest for scientific researchers, who have proved their 
extremely richness in natural biomolecules, conferring a multitude of biological 
properties. Their phytochemical potential, synergistic effects, and mechanisms of action 
have been studied, in different areas of knowledge (Alves-Silva et al., 2013; Shojaii and 
Fard, 2012; Singh et al., 2010). However, many extracts/compounds from plant origin 
remain unstudied. 
In parallel with these advances on plant products research, microbiological area has 
been subjected to severe modifications. A wide variety of microorganisms exist in the 
commensal flora of healthy population, providing several benefits to the host. However, 
in the last two decades, some species have presented an abnormal overgrowth and they 
become harmful, affecting directly not only the welfare, but also the life of individuals 
(Kim and Sudbery, 2011; Mayer et al., 2013; Tsai et al., 2013).  
Opportunistic fungal infections, namely Candida species, comprise the most common 
deep pathogenic infections, being observed not only in immunocompromised patients, 
but also around the hospital and even in the rest of the population (Abi-Said et al., 1997; 
Eggimann et al., 2003; Li et al., 2006; Raman et al., 2013). Candida albicans has been 
considered the most relevant species in the mentioned infections, nevertheless, other 
Candida species have been, currently, pointed out, such as Candida tropicalis, C. 
glabrata, C. dubliniensis, C. parapsilosis, C. orthopsilosis, C. metapsilosis, C. krusei, 
	   4	  
C. famata, C. guilliermondii and C. lusitaniae (Brunke and Hube, 2013; Ferreira et al., 
2013; Kim and Sudbery, 2011; Mayer et al., 2013; Sardi et al., 2013). 
Concomitantly, increasing rates of drug-resistant pathogenic microorganisms have been 
observed, in part due to the indiscriminate use of some antimicrobial agents (Kanafani 
and Perfect, 2008; Sangamwar et al., 2008; Sanglard and Odds, 2002; Sanglard, 2002; 
White et al., 1998). Some advances in pharmaceutical industries have been achieved, 
towards the synthesis and/or preparation of new antifungal drugs more effective and 
selective than the previous (Perlin, 2014, 2009; Sangamwar et al., 2008), but, some 
crucial aspects need to be considered, such as their safety, tolerability and even side 
effects. Recent studies have been carried out accessing the antifungal potential of some 
plant species, but essential oils are the main used extract preparations. Despite the 
existence of other solvents that have also been used in extraction procedures (i.e., 
ethanol, alcohol, methanol, ethyl acetate, dichloromethane, water, among others), some 
evidences show that when a small portion of water is added to the organic solvent, the 
phenolic extraction is improved. Therefore, considering that natural extracts/compounds 
from plant origin could play an important role in the development of antifungal agents, 
the aim of the present work is to identify and highlight the potential of hydromethanolic 
extracts prepared from ten different plants commonly used in folk medicine against 
Candida species. 
 
2. Materials and methods 
2.1. Samples 
A total of ten medicinal plants, commonly used in folk medicine, were studied; four 
were wild harvested in Trás-os-Montes – Bragança, Northeastern Portugal: flower buds 
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and fully opened flowers of Rubus ulmifolius Schott (elm-leaved blackberry), petals of 
Rosa canina L. (rose hips/dogrose), and leaves of Juglans regia L. (walnut). The other 
seven were commercial samples: leaves of Melissa officinalis L. (lemonbalm), aerial 
parts of Foeniculum vulgare Miller (fennel), Matricaria recutita L. (chamomile) and 
Echinacea purpurea (L.) Moench (purple coneflower), and leaves of Eucalyptus 
globulus Labill. (blue gum), Tabebuia impetiginosa (Mart. ex DC) Standley (pau 
d’arco) and flowering parts of Pterospartum tridentatum (L.) Willk. (carqueja). Plant 
scientific nomenclature according to The Plant List (2013), version 1.1 (2013). 
 
2.2. Standards and reagents 
Methanol was of analytical grade purity and supplied by Pronalab (Lisbon, Portugal). 
RPMI 1640 medium was purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
Sabouraud Dextrose Broth (SDB) and Agar were from Merck (Darmstadt, Germany). 
Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, 
Greenville, SC, USA). 
 
2.3. Preparation of the hydromethanolic extracts 
Hydromethanolic extracts were obtained by extracting the sample (1 g) with 30 mL of 
methanol:water (80:20, v/v) at 25 ºC and 150 rpm for 1 h, and filtering through 
Whatman No. 4 paper. The final residue was then extracted with an additional 30 mL 
portion of the hydromethanolic mixture. The combined extracts were evaporated at 35 
ºC under reduced pressure (rotary evaporator Büchi R-210, Flawil, Switzerland) and 
then lyophilized (FreeZone 4.5, Labconco, Kansas City, MO, USA). The lyophilized 
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hydromethanolic extracts, were re-dissolved in water, performing stock solutions with 
concentrations of 50 mg/mL, from which several dilutions were prepared. 
 
2.4. Antifungal activity 
2.4.1. Disc diffusion assay 
Nineteen Candida strains were used during this study (Table 1), four from the 
American Type Culture Collection (ATCC), and fifteen clinical isolates from vaginal 
and urinary tracts and oral cavity. The clinical isolates were obtained from the archive 
collection of the biofilm group of the Centre of Biological Engineering, University of 
Minho, Braga - Portugal. Before each experiment, all strains were grown in Sabouraud 
Dextrose Agar (SDA) for 24h at 37 ºC. After that time, one loop of each colony of cells 
was transferred to SDB liquid medium and incubated under stirring at 37 ºC during 24h. 
An aliquot of each species (300 µL), containing approximately 1×105 cells/mL was 
spread in SDA Petri dishes. Then, an aliquot (25 µL) of each hydromethanolic plant 
extracts, with a known concentration (50 mg/mL), was placed on a sterile blank disc. 
Sterile water was used as negative control. The plates were incubated at 37 ºC, during 
24-48h. The evaluation of inhibitory properties was performed measuring the 
corresponding zone of inhibition. However, when there was no evident halo, but some 
inhibition of growth, the effect was also classified as: (+) cell growth inhibition; (++) 
cell density reduction; (+++) cell density reduction and growth inhibition. 
 
2.4.2. Minimal inhibitory concentrations (MIC) 
Minimal inhibitory concentrations were determined for the plant extracts that 
demonstrated the most pronounced positive results in the disc diffusion test, according 
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with the guidelines from the Nature Protocols (Wiegand et al., 2008), with some 
modifications. Afterwards, a colony recovered from the SDA was suspended in 5 mL of 
sterile saline solution (0.85% NaCl) and vortexed for 15s. The resulting suspension was 
adjusted by adding saline solution to reach the value of 0.5 in McFarland scale. 
Successive dilutions of each plant extract (0.1875; 0.375; 0.75; 1.5 mg/mL) were 
prepared in RPMI 1640 medium at pH 7. Aliquots of each plant extract (100 µL), were 
dispensed into a 96-well plates (Orange Scientific, Braine-l’Alleud, Belgium) and 
further incubated with aliquots (100 µL) of the tested Candida species. Sample and 
yeast -free controls were also included. The 96-well plates were incubated at 37 ºC for 
48 h. After visualization of the resultant plate, the MIC values were correspondent to 
the antifungal concentration where there was no growth, or even fungistatic effect, by 
comparison with the control (cells grown without extracts). The number of viable cells 
was assessed by the determination of number of colony forming units (CFUs), through 
several dilutions, after 24h of incubation at 37 ºC and the number of colonies formed 
were counted. The results were presented as the total of CFUs (Log CFUs) and the 
experiments were repeated in triplicate on three different occasions.  
 
2.5. Statistical analysis  
The results were analyzed using one-way analysis of variance (ANOVA) and means 
were compared using Tukey’s honestly significant difference (HSD) multiple 
comparisons test and further coupled to Welch to verify the equality of means. All 
statistical tests were performed using IBM SPSS Statistics for Windows, version 22.0. 
(IBM Corp., USA). 
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3. Results and discussion 
The results of the antifungal activity screening of the tested hydromethanolic extracts, 
against nineteen Candida strains are presented in Table 1. No evident halo formation 
was observed for Echinacea purpurea, Foeniculum vulgare, Matricaria recutita, 
Melissa officinalis, Rosa canina and Tabebuia impetiginosa, while in Eucalyptus 
globulus, Juglans regia, Pterospartum tridentatum and Rubus ulmifolius plant extracts, 
the halo diameters ranged between 9-21 mm. Juglans regia extract was the most 
effective one, presenting an evident halo for all the tested Candida strains (varying 
between 9-14 mm). Eucalyptus globulus extract also presented a significant antifungal 
potential, being effective against seventeen Candida strains (diameter of halo ranging 
between 9-21 mm). Pterospartum tridentatum and Rubus ulmifolius presented similar 
antifungal effects, being effective against six Candida strains, belonging to C. albicans, 
C. glabrata and C. parapsilosis species. Moreover, the majority of C. tropicalis strains 
were resistant to both tested extracts. No evident antifungal activity was also observed 
for Rosa canina. This work revealed that, in general, C. glabrata strains were the most 
susceptible Candida species, followed by C. albicans, C. parapsilosis and, lastly, C. 
tropicalis strains. 
Some previous reports have described the antimicrobial properties of those medicinal 
plants, namely Foeniculum vulgare essential oil (Roby et al., 2013), Melissa officinalis 
ethanol extract (Ertürk, 2006; Uzun et al., 2004), Rosa canina aqueous extract (Orhan et 
al., 2012), and Juglans regia methanol, ethyl acetate, and acetone extracts (Noumi et al., 
2011, 2010), remaining unstudied the hydromethanolic extract preparations. In fact, 
there are some evidences confirming the high diversity of chemical compounds 
solubility and, therefore, the extraction solvent affect the extracts bioactivity. In this 
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sense, and in order to understand the effects of hydromethanolic extract preparations, 
minimal inhibitory concentrations were determined for the plant extracts that 
demonstrated positive results in the initial screening (Table 1).  
Thus, the MIC values were determined for Eucalyptus globulus and Juglans regia 
extracts (Figure 1 and Figure 2, respectively) against C. tropicalis strains (n=7), C. 
parapsilosis strains (n=5), C. glabrata (n=3) and C. albicans (n=4). The obtained results 
revealed that both extracts exerted more fungistatic than fungicidal effect, since they 
only caused a considerable CFUs reduction, without evidences of a full growth 
inhibition. Moreover, all the obtained results are in accordance with the previous assay 
(disc diffusion assay). For example, E. globulus showed a growth reduction between 2 
and 5 Log (CFUs), in all the tested C. parapsilosis (MIC50=0.1875 mg/mL), followed 
by C. glabrata (MIC50=0.1875 mg/mL) and some C. tropicalis strains, namely ATCC 
750, 12, 544123, 519467 and T2.2 (0.1875<MIC50<1.5 mg/mL). While those Candida 
species were the most sensible to E. globulus extract, C. albicans strains were less 
sensible (MIC50≥1.5 mg/mL). Otherwise, for J. regia, the tested C. parapsilosis 
(0.1875<MIC50<1.5 mg/mL) and C. tropicalis (MIC50≈0.1875 mg/mL) strains were the 
most sensible. The Log CFUs reduction ranged between 3 and 5, while for C. albicans 
(MIC50≥1.5 mg/mL) and C. glabrata (MIC50≥1.5mg/mL) strains ranged between 0.5 
and 2.5 Log (CFUs), corresponding to a higher resistance.  
Overall, and despite the need of further studies to elucidate the mechanisms of action of 
the tested plant extracts, as well as to test their in vivo efficacy, it is possible to conclude 
that hydromethanolic extracts of E. globulus and J. regia could constitute promissory 
alternatives to the current antifungal agents.  
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Table 1. Antifungal activity of hydromethanolic extracts from different plant origin, against several Candida species 
Species Strains Origin 
Inhibition zones (mm) 
Echinacea 
purpurea 
Eucalyptus 
globulus 
Foeniculum 
vulgare  
Juglans 
regia  
Matricaria 
recutita  
Melissa 
officinalis  
Pterospartum 
tridentatum 
Rosa 
canina  
Rubus 
ulmifolius 
Tabebuia 
impetiginosa  
C. albicans 
ATCC 90028 Reference - 10 - 13 - - 10 - 10 - 
575541 Urinary - 12 - 13 - - - - 9 - 
557834 Vaginal - 12 - 12 - + 10 ++ 10 - 
558234 Vaginal - 11 - 12 - - 9 - 15 ++ 
C. glabrata 
ATCC 2001 Reference - 21 - 14 - - 11 - 19 - 
D1 Oral - 13 - 12 - - 11 - ++ - 
513100 Urinary - 11 - 10 - - 9 - 16 - 
C. parapsilosis 
ATCC 22019 Reference ++ 10 ++ 12 - - ++ - - - 
AM2 Oral - 9 - 12 - - ++ - ++ - 
AD Oral - 18 - 12 - - - - + + 
491861 Vaginal - + ++ 11 +++ - - - ++ +++ 
513143 Vaginal - 12 - 10 + - - - - - 
C. tropicalis 
ATCC 750 Reference - 13 - 11 - - + - - - 
AG1 Oral - 11 ++ 12 - - +++ - - - 
75 Vaginal - 12 - 10 - - - - ++ - 
12 Vaginal - +++ - 9 - - - - - - 
544123 Urinary - 9 - 10 - - - - - - 
519468 Urinary - 10 - 10 - - - - - - 
T2.2 Oral - 9 - 10 - - - - - - 
(-) absence of antifungal effect; (+) cell growth inhibition; (++) cell density reduction; (+++) cell density reduction and growth inhibition. 
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Figure 1. Logarithm of number of colony forming units (CFUs) of different strains of C. albicans (A), C. 
glabrata (B), C. parapsilosis (C) and C. tropicalis (D) cultured within different concentrations of the 
hydromethanolic extract of Eucalyptus globulus. Error bars represent standard deviations (SD). *P<0.05, 
** P<0.005 and *** P<0.001), extract concentrations results that are significantly different. In each strain 
different letters mean significant differences (p<0.05). 
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Figure 2. Logarithm of number of colony forming units (CFUs) of different strains of C. albicans (A), C. 
glabrata (B), C. parapsilosis (C) and C. tropicalis (D) cultured within different concentrations of the 
hydromethanolic extract of Juglans regia. Error bars represent standard deviations (SD). *P<0.05, ** 
P<0.005 and *** P<0.001), extract concentrations results that are significantly different. In each strain 
different letters mean significant differences (p<0.05). 
 
